Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Feb 1;173(2):499-502.
doi: 10.1084/jem.173.2.499.

Expression of perforin and serine esterases by human gamma/delta T cells

Affiliations

Expression of perforin and serine esterases by human gamma/delta T cells

H Koizumi et al. J Exp Med. .

Abstract

gamma/delta T cells have recently been described in association with a number of disorders, including autoimmune diseases. gamma/delta T cells are thought to play a cytotoxic role, but their mechanism of action is not known. Several granule mediators of cytotoxicity, including a pore-forming protein (perforin), and a family of serine esterases, have been isolated from cytotoxic T lymphocytes (CTL), lymphokine-activated killer (LAK) cells, and natural killer (NK) cells. We demonstrate here that gamma/delta T cells also express these mediators. Northern blots show that gamma/delta T cells express perforin, serine esterase 1 (SE 1), and SE 2. Three polyclonal antisera - raised against murine perforin, a peptide composed of amino acids 1-34 of human perforin, and human peforin expressed in bacteria - all reacted with a 70-kD protein in gamma/delta T cells on Western blots. Immunostaining with antiperforin antisera shows that primary gamma/delta T cells also contain perforin. Electron microscopy reveals that the granules of gamma/delta T cells resemble those of CTL, LAK, and NK cells. Gamma/delta T cells also resemble LAK cells in possessing inclusion bodies in their nuclei. These results imply that gamma/delta T cells resemble other cytolytic lymphocytes in their mechanism of action.

PubMed Disclaimer

References

    1. Immunol Lett. 1990 Jan;23(3):195-8 - PubMed
    1. Nature. 1989 Jun 15;339(6225):544-8 - PubMed
    1. N Engl J Med. 1990 Jan 11;322(2):73-6 - PubMed
    1. Acta Haematol. 1990;83(4):193-7 - PubMed
    1. J Clin Invest. 1990 May;85(5):1353-61 - PubMed

Publication types

MeSH terms